Antibody Therapeutics
Software Powering the Next Generation of Antibody R&D | Benchling
![](https://knect365.imgix.net/uploads/2354c48f-3392-47b3-b1c3-67134ea0a880-featured-055f2904327f7d0c45994131f113df01.png?auto=format&fit=max)
Benchling Solutions Delivery Manager Andrew Mecca shares why antibody therapeutics are on the rise and how companies are leveraging Benchling’s technology to handle the complexity of modern antibody R&D.